Clinical Laboratory Testing Market, 2024: CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensiv...
January 19 2017 - 1:02PM
Business Wire
Research and Markets has announced the addition of the "Clinical
Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN
Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive
Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), By
End-use, And Segment Forecasts, 2013 - 2024" report to their
offering.
The global clinical laboratory testing market is expected to
reach USD 198.5 billion by 2024.
Introduction of innovative solutions on the grounds of maximum
efficiency and minimum error is expected to serve this market as a
high impact-rendering driver.
Integrated workflow management systems, database management
tools and patient test records are becoming increasingly important
in the healthcare industry with companies processing as many as 100
to 150 billion samples per year.
Development and implementation of various informatics and data
management solutions for performing seamless operations is expected
to drive the growth of this market. Availability of technologically
advanced products such as chemistry analyzers with high yield, low
maintenance, and ease of usage has heightened the demand for early
disease detection.
Increasing prevalence of chronic diseases and the consequent
need to curb healthcare expenditure is also expected to drive
market growth by increasing the demand for early and regular
disease diagnosis. Moreover, presence of favorable reimbursement
policies and availability of CLIA waived test is anticipated to
increase base of target population.
Further Key Findings From the Study Suggest:
- The basic metabolic panel segment dominated the clinical
laboratory test market in 2015 mainly due to high acceptance rate
of this panel of tests.
- Liver panel is estimated to witness highest growth for liver
cirrhosis testing owing to high rate of alcohol consumption.
- Increasing demand for testing of blood lipid levels in
cardiovascular and diabetes patients is anticipated to attribute
towards significant growth of liver panel over the forecast
period.
- Extensive support of manpower and established infrastructure
are the main factors attributing to largest share of central
laboratories.
- North America is the most developed clinical laboratory tests
market due to factors such as high awareness levels, rising
prevalence of cardiovascular disorders, and high market penetration
of technologically advanced diagnostic techniques.
- Asia Pacific is anticipated to witness significant growth over
9% during the forecast period with presence of huge untapped
opportunities, increasing base of target population, and positive
economic growth.
- Some of the key companies are Quest Diagnostics, Millipore
Sigma, LabCorp, and Genoptix Medical Laboratory.
- Strategic initiatives implemented by key players to maintain
market position include merger and acquisition of small players and
development of cost effective clinical tests.
Company Profiles
- Abbott Laboratories
- ARUP Laboratories (Associated Regional & University
Pathologists Inc.)
- OPKO Health, Inc. (Bio-Reference Labs)
- Bioscientia Institut für Medizinische Diagnostik GmbH
- Charles River Laboratories International, Inc.
- Neogenomics Laboratories, Inc. (Clarient, Inc.)
- Genoptix
- Healthscope
- Labco S.A
- Laboratory Corporation of America Holdings (LabCorp)
- Qiagen N.V
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare Ltd.
- Spectra Laboratories (Fresenius Medical Care Holdings,
Inc.)
- Merck KgaA (Merck Millipore Sigma)
- Tulip Group
- Biosino Bio-technology and Science Inc
For more information about this report visit
http://www.researchandmarkets.com/research/6b7wkd/clinical
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170119006048/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Related Topics: Laboratory Testing